Industry: Food & Beverages
Published Date: 2026-01-08
Pages: 144 Pages
Report ld: 5589078
Request Sample
Customized Report
Affinity Chromatography Column for Mycotoxins Market Size(US$)

CAGR 2026-2032
6.0%
Market Size,2032
USD 311
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Affinity Chromatography Column for Mycotoxins market was valued at US$ 208 million in 2025 and is anticipated to reach US$ 311 million by 2032, at a CAGR of 6.0% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Affinity Chromatography Column for Mycotoxins competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
An Affinity Chromatography Column for Mycotoxins is a specialized chromatographic column designed for the selective separation and purification of mycotoxins from complex mixtures, such as food, feed, and agricultural products. Mycotoxins are toxic compounds produced by certain molds (fungi) that can contaminate crops and pose serious health risks to humans and animals. These columns use the principles of affinity chromatography, which relies on the specific interaction between the target molecule (in this case, mycotoxins) and a ligand that is immobilized on the stationary phase of the column.
The North American market for Affinity Chromatography Column for Mycotoxins is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Affinity Chromatography Column for Mycotoxins is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Affinity Chromatography Column for Mycotoxins include Gold Standard Diagnostics Horsham, LCTech, Shimadzu, Biotez Berlin, PerkinElmer, VICAM, Ring Biotechnology, R-Biopharm AG, CHROMATIFIC, Neogen, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Affinity Chromatography Column for Mycotoxins market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Affinity Chromatography Column for Mycotoxins. The Affinity Chromatography Column for Mycotoxins market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Affinity Chromatography Column for Mycotoxins market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Affinity Chromatography Column for Mycotoxins manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Affinity Chromatography Column for Mycotoxins manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Affinity Chromatography Column for Mycotoxins sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Affinity Chromatography Column for Mycotoxins Market Overview
1.1 Product Definition
1.2 Affinity Chromatography Column for Mycotoxins by Type
1.2.1 Global Affinity Chromatography Column for Mycotoxins Market Value by Type: 2025 vs 2032
1.2.2 Aflatoxins
1.2.3 Ochratoxin
1.2.4 Zearalenone
1.2.5 Deoxynivalenol
1.2.6 Fumonisins
1.2.7 Others
1.3 Affinity Chromatography Column for Mycotoxins by Application
1.3.1 Global Affinity Chromatography Column for Mycotoxins Market Value by Application: 2025 vs 2032
1.3.2 Food
1.3.3 Feed
1.3.4 Others
1.4 Global Affinity Chromatography Column for Mycotoxins Market Size Estimates and Forecasts
1.4.1 Global Affinity Chromatography Column for Mycotoxins Revenue 2021–2032
1.4.2 Global Affinity Chromatography Column for Mycotoxins Sales 2021–2032
1.4.3 Global Affinity Chromatography Column for Mycotoxins Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Affinity Chromatography Column for Mycotoxins Market Competition by Manufacturers
2.1 Global Affinity Chromatography Column for Mycotoxins Sales Market Share by Manufacturers (2021–2026)
2.2 Global Affinity Chromatography Column for Mycotoxins Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Affinity Chromatography Column for Mycotoxins Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Affinity Chromatography Column for Mycotoxins, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Affinity Chromatography Column for Mycotoxins, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Affinity Chromatography Column for Mycotoxins, Product Types and Applications
2.7 Global Key Manufacturers of Affinity Chromatography Column for Mycotoxins, Date of Entry into the Industry
2.8 Global Affinity Chromatography Column for Mycotoxins Market Competitive Situation and Trends
2.8.1 Global Affinity Chromatography Column for Mycotoxins Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Affinity Chromatography Column for Mycotoxins Players Market Share by Revenue
2.8.3 Global Affinity Chromatography Column for Mycotoxins Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Affinity Chromatography Column for Mycotoxins Market Scenario by Region
3.1 Global Affinity Chromatography Column for Mycotoxins Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Affinity Chromatography Column for Mycotoxins Sales by Region: 2021–2032
3.2.1 Global Affinity Chromatography Column for Mycotoxins Sales by Region: 2021–2026
3.2.2 Global Affinity Chromatography Column for Mycotoxins Sales by Region: 2027–2032
3.3 Global Affinity Chromatography Column for Mycotoxins Revenue by Region: 2021–2032
3.3.1 Global Affinity Chromatography Column for Mycotoxins Revenue by Region: 2021–2026
3.3.2 Global Affinity Chromatography Column for Mycotoxins Revenue by Region: 2027–2032
3.4 North America Affinity Chromatography Column for Mycotoxins Market Facts & Figures by Country
3.4.1 North America Affinity Chromatography Column for Mycotoxins Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Affinity Chromatography Column for Mycotoxins Sales by Country (2021–2032)
3.4.3 North America Affinity Chromatography Column for Mycotoxins Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Affinity Chromatography Column for Mycotoxins Market Facts & Figures by Country
3.5.1 Europe Affinity Chromatography Column for Mycotoxins Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Affinity Chromatography Column for Mycotoxins Sales by Country (2021–2032)
3.5.3 Europe Affinity Chromatography Column for Mycotoxins Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Affinity Chromatography Column for Mycotoxins Market Facts & Figures by Region
3.6.1 Asia Pacific Affinity Chromatography Column for Mycotoxins Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Affinity Chromatography Column for Mycotoxins Sales by Region (2021–2032)
3.6.3 Asia Pacific Affinity Chromatography Column for Mycotoxins Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Affinity Chromatography Column for Mycotoxins Market Facts & Figures by Country
3.7.1 Latin America Affinity Chromatography Column for Mycotoxins Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Affinity Chromatography Column for Mycotoxins Sales by Country (2021–2032)
3.7.3 Latin America Affinity Chromatography Column for Mycotoxins Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Affinity Chromatography Column for Mycotoxins Market Facts & Figures by Country
3.8.1 Middle East and Africa Affinity Chromatography Column for Mycotoxins Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Affinity Chromatography Column for Mycotoxins Sales by Country (2021–2032)
3.8.3 Middle East and Africa Affinity Chromatography Column for Mycotoxins Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Affinity Chromatography Column for Mycotoxins Sales by Type (2021–2032)
4.1.1 Global Affinity Chromatography Column for Mycotoxins Sales by Type (2021–2026)
4.1.2 Global Affinity Chromatography Column for Mycotoxins Sales by Type (2027–2032)
4.1.3 Global Affinity Chromatography Column for Mycotoxins Sales Market Share by Type (2021–2032)
4.2 Global Affinity Chromatography Column for Mycotoxins Revenue by Type (2021–2032)
4.2.1 Global Affinity Chromatography Column for Mycotoxins Revenue by Type (2021–2026)
4.2.2 Global Affinity Chromatography Column for Mycotoxins Revenue by Type (2027–2032)
4.2.3 Global Affinity Chromatography Column for Mycotoxins Revenue Market Share by Type (2021–2032)
4.3 Global Affinity Chromatography Column for Mycotoxins Price by Type (2021–2032)
5 Segment by Application
5.1 Global Affinity Chromatography Column for Mycotoxins Sales by Application (2021–2032)
5.1.1 Global Affinity Chromatography Column for Mycotoxins Sales by Application (2021–2026)
5.1.2 Global Affinity Chromatography Column for Mycotoxins Sales by Application (2027–2032)
5.1.3 Global Affinity Chromatography Column for Mycotoxins Sales Market Share by Application (2021–2032)
5.2 Global Affinity Chromatography Column for Mycotoxins Revenue by Application (2021–2032)
5.2.1 Global Affinity Chromatography Column for Mycotoxins Revenue by Application (2021–2026)
5.2.2 Global Affinity Chromatography Column for Mycotoxins Revenue by Application (2027–2032)
5.2.3 Global Affinity Chromatography Column for Mycotoxins Revenue Market Share by Application (2021–2032)
5.3 Global Affinity Chromatography Column for Mycotoxins Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Gold Standard Diagnostics Horsham
6.1.1 Gold Standard Diagnostics Horsham Company Information
6.1.2 Gold Standard Diagnostics Horsham Description and Business Overview
6.1.3 Gold Standard Diagnostics Horsham Affinity Chromatography Column for Mycotoxins Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Gold Standard Diagnostics Horsham Affinity Chromatography Column for Mycotoxins Product Portfolio
6.1.5 Gold Standard Diagnostics Horsham Recent Developments/Updates
6.2 LCTech
6.2.1 LCTech Company Information
6.2.2 LCTech Description and Business Overview
6.2.3 LCTech Affinity Chromatography Column for Mycotoxins Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 LCTech Affinity Chromatography Column for Mycotoxins Product Portfolio
6.2.5 LCTech Recent Developments/Updates
6.3 Shimadzu
6.3.1 Shimadzu Company Information
6.3.2 Shimadzu Description and Business Overview
6.3.3 Shimadzu Affinity Chromatography Column for Mycotoxins Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Shimadzu Affinity Chromatography Column for Mycotoxins Product Portfolio
6.3.5 Shimadzu Recent Developments/Updates
6.4 Biotez Berlin
6.4.1 Biotez Berlin Company Information
6.4.2 Biotez Berlin Description and Business Overview
6.4.3 Biotez Berlin Affinity Chromatography Column for Mycotoxins Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Biotez Berlin Affinity Chromatography Column for Mycotoxins Product Portfolio
6.4.5 Biotez Berlin Recent Developments/Updates
6.5 PerkinElmer
6.5.1 PerkinElmer Company Information
6.5.2 PerkinElmer Description and Business Overview
6.5.3 PerkinElmer Affinity Chromatography Column for Mycotoxins Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 PerkinElmer Affinity Chromatography Column for Mycotoxins Product Portfolio
6.5.5 PerkinElmer Recent Developments/Updates
6.6 VICAM
6.6.1 VICAM Company Information
6.6.2 VICAM Description and Business Overview
6.6.3 VICAM Affinity Chromatography Column for Mycotoxins Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 VICAM Affinity Chromatography Column for Mycotoxins Product Portfolio
6.6.5 VICAM Recent Developments/Updates
6.7 Ring Biotechnology
6.7.1 Ring Biotechnology Company Information
6.7.2 Ring Biotechnology Description and Business Overview
6.7.3 Ring Biotechnology Affinity Chromatography Column for Mycotoxins Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Ring Biotechnology Affinity Chromatography Column for Mycotoxins Product Portfolio
6.7.5 Ring Biotechnology Recent Developments/Updates
6.8 R-Biopharm AG
6.8.1 R-Biopharm AG Company Information
6.8.2 R-Biopharm AG Description and Business Overview
6.8.3 R-Biopharm AG Affinity Chromatography Column for Mycotoxins Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 R-Biopharm AG Affinity Chromatography Column for Mycotoxins Product Portfolio
6.8.5 R-Biopharm AG Recent Developments/Updates
6.9 CHROMATIFIC
6.9.1 CHROMATIFIC Company Information
6.9.2 CHROMATIFIC Description and Business Overview
6.9.3 CHROMATIFIC Affinity Chromatography Column for Mycotoxins Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 CHROMATIFIC Affinity Chromatography Column for Mycotoxins Product Portfolio
6.9.5 CHROMATIFIC Recent Developments/Updates
6.10 Neogen
6.10.1 Neogen Company Information
6.10.2 Neogen Description and Business Overview
6.10.3 Neogen Affinity Chromatography Column for Mycotoxins Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Neogen Affinity Chromatography Column for Mycotoxins Product Portfolio
6.10.5 Neogen Recent Developments/Updates
6.11 Shenzhen Bioeasy Biotechnology
6.11.1 Shenzhen Bioeasy Biotechnology Company Information
6.11.2 Shenzhen Bioeasy Biotechnology Description and Business Overview
6.11.3 Shenzhen Bioeasy Biotechnology Affinity Chromatography Column for Mycotoxins Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Shenzhen Bioeasy Biotechnology Affinity Chromatography Column for Mycotoxins Product Portfolio
6.11.5 Shenzhen Bioeasy Biotechnology Recent Developments/Updates
6.12 Kwinbon Biotechnology
6.12.1 Kwinbon Biotechnology Company Information
6.12.2 Kwinbon Biotechnology Description and Business Overview
6.12.3 Kwinbon Biotechnology Affinity Chromatography Column for Mycotoxins Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Kwinbon Biotechnology Affinity Chromatography Column for Mycotoxins Product Portfolio
6.12.5 Kwinbon Biotechnology Recent Developments/Updates
6.13 Shandong Meizheng Bio-Tech
6.13.1 Shandong Meizheng Bio-Tech Company Information
6.13.2 Shandong Meizheng Bio-Tech Description and Business Overview
6.13.3 Shandong Meizheng Bio-Tech Affinity Chromatography Column for Mycotoxins Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Shandong Meizheng Bio-Tech Affinity Chromatography Column for Mycotoxins Product Portfolio
6.13.5 Shandong Meizheng Bio-Tech Recent Developments/Updates
6.14 Shandong Lvdu Bio-Sciences & Technology
6.14.1 Shandong Lvdu Bio-Sciences & Technology Company Information
6.14.2 Shandong Lvdu Bio-Sciences & Technology Description and Business Overview
6.14.3 Shandong Lvdu Bio-Sciences & Technology Affinity Chromatography Column for Mycotoxins Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Shandong Lvdu Bio-Sciences & Technology Affinity Chromatography Column for Mycotoxins Product Portfolio
6.14.5 Shandong Lvdu Bio-Sciences & Technology Recent Developments/Updates
6.15 Beijing Nano-Ace Technology
6.15.1 Beijing Nano-Ace Technology Company Information
6.15.2 Beijing Nano-Ace Technology Description and Business Overview
6.15.3 Beijing Nano-Ace Technology Affinity Chromatography Column for Mycotoxins Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Beijing Nano-Ace Technology Affinity Chromatography Column for Mycotoxins Product Portfolio
6.15.5 Beijing Nano-Ace Technology Recent Developments/Updates
6.16 Pribolab
6.16.1 Pribolab Company Information
6.16.2 Pribolab Description and Business Overview
6.16.3 Pribolab Affinity Chromatography Column for Mycotoxins Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Pribolab Affinity Chromatography Column for Mycotoxins Product Portfolio
6.16.5 Pribolab Recent Developments/Updates
6.17 Jiangsu Suwei Micro-Biology Research
6.17.1 Jiangsu Suwei Micro-Biology Research Company Information
6.17.2 Jiangsu Suwei Micro-Biology Research Description and Business Overview
6.17.3 Jiangsu Suwei Micro-Biology Research Affinity Chromatography Column for Mycotoxins Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Jiangsu Suwei Micro-Biology Research Affinity Chromatography Column for Mycotoxins Product Portfolio
6.17.5 Jiangsu Suwei Micro-Biology Research Recent Developments/Updates
6.18 BIOCOMMA
6.18.1 BIOCOMMA Company Information
6.18.2 BIOCOMMA Description and Business Overview
6.18.3 BIOCOMMA Affinity Chromatography Column for Mycotoxins Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 BIOCOMMA Affinity Chromatography Column for Mycotoxins Product Portfolio
6.18.5 BIOCOMMA Recent Developments/Updates
6.19 Jiangsu Wisdom Engineering & Technology
6.19.1 Jiangsu Wisdom Engineering & Technology Company Information
6.19.2 Jiangsu Wisdom Engineering & Technology Description and Business Overview
6.19.3 Jiangsu Wisdom Engineering & Technology Affinity Chromatography Column for Mycotoxins Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Jiangsu Wisdom Engineering & Technology Affinity Chromatography Column for Mycotoxins Product Portfolio
6.19.5 Jiangsu Wisdom Engineering & Technology Recent Developments/Updates
6.20 Anavo
6.20.1 Anavo Company Information
6.20.2 Anavo Description and Business Overview
6.20.3 Anavo Affinity Chromatography Column for Mycotoxins Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Anavo Affinity Chromatography Column for Mycotoxins Product Portfolio
6.20.5 Anavo Recent Developments/Updates
6.21 Prufunglab
6.21.1 Prufunglab Company Information
6.21.2 Prufunglab Description and Business Overview
6.21.3 Prufunglab Affinity Chromatography Column for Mycotoxins Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 Prufunglab Affinity Chromatography Column for Mycotoxins Product Portfolio
6.21.5 Prufunglab Recent Developments/Updates
6.22 Femdetection
6.22.1 Femdetection Company Information
6.22.2 Femdetection Description and Business Overview
6.22.3 Femdetection Affinity Chromatography Column for Mycotoxins Sales, Revenue, and Gross Margin (2021–2026)
6.22.4 Femdetection Affinity Chromatography Column for Mycotoxins Product Portfolio
6.22.5 Femdetection Recent Developments/Updates
6.23 Welch Materials
6.23.1 Welch Materials Company Information
6.23.2 Welch Materials Description and Business Overview
6.23.3 Welch Materials Affinity Chromatography Column for Mycotoxins Sales, Revenue, and Gross Margin (2021–2026)
6.23.4 Welch Materials Affinity Chromatography Column for Mycotoxins Product Portfolio
6.23.5 Welch Materials Recent Developments/Updates
6.24 Wuhan Huamei Wisherkon Biotech
6.24.1 Wuhan Huamei Wisherkon Biotech Company Information
6.24.2 Wuhan Huamei Wisherkon Biotech Description and Business Overview
6.24.3 Wuhan Huamei Wisherkon Biotech Affinity Chromatography Column for Mycotoxins Sales, Revenue, and Gross Margin (2021–2026)
6.24.4 Wuhan Huamei Wisherkon Biotech Affinity Chromatography Column for Mycotoxins Product Portfolio
6.24.5 Wuhan Huamei Wisherkon Biotech Recent Developments/Updates
6.25 Shandong Vnya Bio-technology
6.25.1 Shandong Vnya Bio-technology Company Information
6.25.2 Shandong Vnya Bio-technology Description and Business Overview
6.25.3 Shandong Vnya Bio-technology Affinity Chromatography Column for Mycotoxins Sales, Revenue, and Gross Margin (2021–2026)
6.25.4 Shandong Vnya Bio-technology Affinity Chromatography Column for Mycotoxins Product Portfolio
6.25.5 Shandong Vnya Bio-technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Affinity Chromatography Column for Mycotoxins Industry Chain Analysis
7.2 Affinity Chromatography Column for Mycotoxins Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Affinity Chromatography Column for Mycotoxins Production Mode & Process Analysis
7.4 Affinity Chromatography Column for Mycotoxins Sales and Marketing
7.4.1 Affinity Chromatography Column for Mycotoxins Sales Channels
7.4.2 Affinity Chromatography Column for Mycotoxins Distributors
7.5 Affinity Chromatography Column for Mycotoxins Customer Analysis
8 Affinity Chromatography Column for Mycotoxins Market Dynamics
8.1 Affinity Chromatography Column for Mycotoxins Industry Trends
8.2 Affinity Chromatography Column for Mycotoxins Market Drivers
8.3 Affinity Chromatography Column for Mycotoxins Market Challenges
8.4 Affinity Chromatography Column for Mycotoxins Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Affinity Chromatography Column for Mycotoxins market is projected to grow from US$ 208 million in 2025 to US$ 311 million by 2032, at a CAGR of 6.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-24
Pages: 191
USD 4900.00
(Single User License)
The global Affinity Chromatography Column for Mycotoxins market size was US$ 208 million in 2025 and is forecast to reach a readjusted size of US$ 311 million by 2032 with a CAGR of 6.0% during the forecast period 2026-2032.
Published Date: 2026-03-24
Pages: 116
USD 4250.00
(Single User License)
The global market for Affinity Chromatography Column for Mycotoxins was estimated to be worth US$ 208 million in 2025 and is projected to reach US$ 311 million, growing at a CAGR of 6.0% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 164
USD 3950.00
(Single User License)
The global Affinity Chromatography Column for Mycotoxins market is projected to grow from US$ 187 million in 2024 to US$ 280 million by 2031, at a CAGR of 6.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 197
USD 4900.00
(Single User License)
The global market for Affinity Chromatography Column for Mycotoxins was estimated to be worth US$ 187 million in 2024 and is forecast to a readjusted size of US$ 280 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 151
USD 3950.00
(Single User License)
The global Affinity Chromatography Column for Mycotoxins market size was US$ 187 million in 2024 and is forecast to a readjusted size of US$ 280 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 116
USD 4250.00
(Single User License)
The global market for Affinity Chromatography Column for Mycotoxins was valued at US$ 187 million in the year 2024 and is projected to reach a revised size of US$ 280 million by 2031, growing at a CAGR of 6.0% during the forecast period.
Published Date: 2025-03-13
Pages: 113
USD 2900.00
(Single User License)
The global market for Affinity Chromatography Column for Mycotoxins was estimated to be worth US$ 187 million in 2024 and is forecast to a readjusted size of US$ 280 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 168
USD 3950.00
(Single User License)
The global market for Affinity Chromatography Column for Mycotoxins was estimated to be worth US$ 187 million in 2023 and is forecast to a readjusted size of US$ 280 million by 2030 with a CAGR of 6.0% during the forecast period 2024-2030.
Published Date: 2025-01-04
Pages: 168
USD 3950.00
(Single User License)
The global market for Affinity Chromatography Column for Mycotoxins was valued at US$ 187 million in the year 2023 and is projected to reach a revised size of US$ 280 million by 2030, growing at a CAGR of 6.0% during the forecast period.
Published Date: 2025-01-04
Pages: 108
USD 2900.00
(Single User License)
The global Affinity Chromatography Column for Mycotoxins market is projected to grow from US$ 208 million in 2025 to US$ 311 million by 2032, at a CAGR of 6.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-24
Pages: 191
The global Affinity Chromatography Column for Mycotoxins market size was US$ 208 million in 2025 and is forecast to reach a readjusted size of US$ 311 million by 2032 with a CAGR of 6.0% during the forecast period 2026-2032.
Published: 2026-03-24
Pages: 116
The global market for Affinity Chromatography Column for Mycotoxins was estimated to be worth US$ 208 million in 2025 and is projected to reach US$ 311 million, growing at a CAGR of 6.0% from 2026 to 2032.
Published: 2026-01-19
Pages: 164
The global Affinity Chromatography Column for Mycotoxins market is projected to grow from US$ 187 million in 2024 to US$ 280 million by 2031, at a CAGR of 6.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 197
The global market for Affinity Chromatography Column for Mycotoxins was estimated to be worth US$ 187 million in 2024 and is forecast to a readjusted size of US$ 280 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 151
The global Affinity Chromatography Column for Mycotoxins market size was US$ 187 million in 2024 and is forecast to a readjusted size of US$ 280 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 116
The global market for Affinity Chromatography Column for Mycotoxins was valued at US$ 187 million in the year 2024 and is projected to reach a revised size of US$ 280 million by 2031, growing at a CAGR of 6.0% during the forecast period.
Published: 2025-03-13
Pages: 113
The global market for Affinity Chromatography Column for Mycotoxins was estimated to be worth US$ 187 million in 2024 and is forecast to a readjusted size of US$ 280 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 168
The global market for Affinity Chromatography Column for Mycotoxins was estimated to be worth US$ 187 million in 2023 and is forecast to a readjusted size of US$ 280 million by 2030 with a CAGR of 6.0% during the forecast period 2024-2030.
Published: 2025-01-04
Pages: 168
The global market for Affinity Chromatography Column for Mycotoxins was valued at US$ 187 million in the year 2023 and is projected to reach a revised size of US$ 280 million by 2030, growing at a CAGR of 6.0% during the forecast period.
Published: 2025-01-04
Pages: 108
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now